erythromycin has been researched along with Esophageal Reflux in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (28.57) | 18.2507 |
| 2000's | 11 (52.38) | 29.6817 |
| 2010's | 4 (19.05) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ballengee, CR; Conaway, MR; Davalian, F; Kaufman, DA; Sauer, CG | 1 |
| Arnold, C; Benjamin, DK; Cheeseman, J; Cho, J; Chu, V; Clark, RH; Ericson, JE; Hornik, CP; Kaneko, S; Smith, PB; Wilson, E | 1 |
| Holloway, RH; Kuo, P | 1 |
| Islam, S; Kahn, G; Moshiree, B; Talley, NJ; Waseem, S | 1 |
| Inauen, W; Netzer, P; Schmitt, B | 1 |
| Gomez, JM; Ng, SC; Quak, SH; Rajadurai, VS; Saw, SM | 1 |
| Batres, LA; Chicella, MF; Dice, JE; Heesters, MS | 1 |
| Hauser, B; Salvatore, S; Vandenplas, Y | 1 |
| Keady, S | 1 |
| Yang, Y | 1 |
| Robinson, M | 1 |
| Ramirez, B; Richter, JE | 1 |
| Cioppi, M; Fayad, J; Little, AG; Pennathur, A; Sieren, GL; Tran, A | 1 |
| Kaess, H; Pehl, C; Pfeiffer, A; Stellwag, B; Wendl, B | 1 |
| Di Lorenzo, C; Flores, AF; Hyman, PE; Idries, S; Lucanto, C | 1 |
| Samsom, M; Smout, AJ; Van Herwaarden, MA; Van Nispen, CH; Verlinden, M | 1 |
| Curry, JI; Lander, TD; Stringer, MD | 1 |
| Chrysos, E; Epanomeritakis, E; Tsiaoussis, J; Tzovaras, G; Vassilakis, JS; Vrachasotakis, N; Xynos, E | 1 |
| Alonso Calderón, JL; García Aroca, J; García Redondo, C; Rollán Villamarín, V | 1 |
| Brinkhoff, H; Chen, CL; Dettmer, A; Krause, R; Lanza, F; Mack, RJ; Orr, WC; Riff, D; Schwartz, S; Soloway, RD; Verlinden, MH | 1 |
| Kaess, H; Pehl, C; Pfeiffer, A; Wendl, B | 1 |
7 review(s) available for erythromycin and Esophageal Reflux
| Article | Year |
|---|---|
Prokinetic drug therapy in children: a review of current options.
Topics: Child; Controlled Clinical Trials as Topic; Erythromycin; Gastroesophageal Reflux; Humans; Metoclopramide | 2005 |
The diagnosis and management of gastro-oesophageal reflux in infants.
Topics: Antacids; Cisapride; Domperidone; Erythromycin; Gastric Mucosa; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Infant; Infant, Newborn; Metoclopramide; Risk Factors | 2005 |
Update on drugs for gastro-oesophageal reflux disease.
Topics: Adolescent; Antacids; Child; Child, Preschool; Cisapride; Contraindications; Domperidone; Erythromycin; Gastroesophageal Reflux; Gastrointestinal Agents; Histamine Antagonists; Humans; Infant; Infant Food; Infant, Newborn; Metoclopramide; Proton Pump Inhibitors | 2007 |
[Mechanism and clinical application of erythromycin as a gastrointestinal prokinetic agent in children].
Topics: Anti-Bacterial Agents; Child; Dyspepsia; Erythromycin; Gastroesophageal Reflux; Gastrointestinal Motility; Humans; Motilin; Receptors, Gastrointestinal Hormone; Receptors, Neuropeptide | 2008 |
Prokinetic therapy for gastroesophageal reflux disease.
Topics: Bethanechol; Cisapride; Domperidone; Erythromycin; Gastroesophageal Reflux; Humans; Metoclopramide; Parasympathomimetics; Piperidines | 1995 |
Review article: promotility drugs in the treatment of gastro-oesophageal reflux disease.
Topics: Adult; Benzamides; Bethanechol; Bethanechol Compounds; Child; Cisapride; Erythromycin; Gastroesophageal Reflux; Gastrointestinal Motility; Humans; Infant; Metoclopramide; Piperidines; Receptors, Cholecystokinin; Serotonin Antagonists | 1993 |
Review article: erythromycin as a prokinetic agent in infants and children.
Topics: Administration, Oral; Child; Child, Preschool; Erythromycin; Gastroesophageal Reflux; Gastrointestinal Agents; Gastrointestinal Motility; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Randomized Controlled Trials as Topic | 2001 |
7 trial(s) available for erythromycin and Esophageal Reflux
| Article | Year |
|---|---|
Erythromycin and Reflux Events in Premature Neonates: A Randomized Clinical Trial.
Topics: Double-Blind Method; Electric Impedance; Erythromycin; Esophageal pH Monitoring; Esophagus; Female; Gastroesophageal Reflux; Gastrointestinal Agents; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature; Male; Treatment Outcome | 2018 |
Effects of ABT-229, a motilin agonist, on acid reflux, oesophageal motility and gastric emptying in patients with gastro-oesophageal reflux disease.
Topics: Adult; Aged; Aged, 80 and over; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Erythromycin; Female; Gastric Emptying; Gastroesophageal Reflux; Gastrointestinal Agents; Gastrointestinal Motility; Humans; Hydrogen-Ion Concentration; Male; Manometry; Middle Aged; Motilin | 2002 |
Establishing enteral feeding in preterm infants with feeding intolerance: a randomized controlled study of low-dose erythromycin.
Topics: Birth Weight; Double-Blind Method; Enteral Nutrition; Erythromycin; Gastroesophageal Reflux; Gastrointestinal Agents; Gestational Age; Humans; Infant Formula; Infant, Newborn; Infant, Premature; Infant, Small for Gestational Age; Milk, Human; Parenteral Nutrition; Placebos; Prospective Studies; Time Factors; Treatment Outcome; Weight Gain | 2003 |
The effect of motilin agonist ABT-229 on gastro-oesophageal reflux, oesophageal motility and lower oesophageal sphincter characteristics in GERD patients.
Topics: Adult; Cisapride; Cross-Over Studies; Double-Blind Method; Erythromycin; Esophagus; Female; Gastroesophageal Reflux; Gastrointestinal Agents; Humans; Hydrogen-Ion Concentration; Male; Manometry; Middle Aged; Motilin | 2000 |
Erythromycin enhances oesophageal motility in patients with gastro-oesophageal reflux.
Topics: Adult; Aged; Double-Blind Method; Erythromycin; Esophageal Motility Disorders; Esophagogastric Junction; Female; Gastric Acidity Determination; Gastric Emptying; Gastroesophageal Reflux; Humans; Injections, Intravenous; Male; Middle Aged; Monitoring, Ambulatory | 2001 |
Efficacy of a motilin receptor agonist (ABT-229) for the treatment of gastro-oesophageal reflux disease.
Topics: Dose-Response Relationship, Drug; Double-Blind Method; Erythromycin; Female; Gastroesophageal Reflux; Humans; Male; Quality of Life; Receptors, Gastrointestinal Hormone; Receptors, Neuropeptide; Surveys and Questionnaires; Treatment Outcome | 2002 |
Effect of erythromycin on gastroesophageal reflux.
Topics: Adult; Erythromycin; Female; Gastric Emptying; Gastroesophageal Reflux; Humans; Hydrogen-Ion Concentration; Male; Reference Values; Wine | 1991 |
7 other study(ies) available for erythromycin and Esophageal Reflux
| Article | Year |
|---|---|
Use and Safety of Erythromycin and Metoclopramide in Hospitalized Infants.
Topics: Enteral Nutrition; Erythromycin; Female; Gastroesophageal Reflux; Gastrointestinal Agents; Humans; Hyperkalemia; Incidence; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Intensive Care Units, Neonatal; Male; Metoclopramide; Pyloric Stenosis, Hypertrophic; Retrospective Studies | 2015 |
Beyond acid suppression: new pharmacologic approaches for treatment of GERD.
Topics: Animals; Baclofen; Cannabinoid Receptor Agonists; Dogs; Dronabinol; Erythromycin; GABA Agonists; GABA-B Receptor Agonists; Gastroesophageal Reflux; Gastrointestinal Agents; Humans; Phosphinic Acids; Propylamines; Proton Pump Inhibitors; Pyridines; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate | 2010 |
Spectrum of gastroparesis in children.
Topics: Abdominal Pain; Adolescent; Child; Child, Preschool; Diabetes Complications; Drug-Related Side Effects and Adverse Reactions; Erythromycin; Female; Follow-Up Studies; Gastric Emptying; Gastroesophageal Reflux; Gastrointestinal Agents; Gastroparesis; Humans; Infant; Male; Nausea; Postoperative Complications; Prevalence; Prognosis; Vomiting; Weight Loss; Young Adult | 2012 |
Erythromycin strengthens the defective lower esophageal sphincter in patients with gastroesophageal reflux disease.
Topics: Erythromycin; Esophagogastric Junction; Female; Gastroesophageal Reflux; Humans; Male; Manometry; Middle Aged; Motilin; Myoelectric Complex, Migrating; Peristalsis; Pressure; Stimulation, Chemical; Time Factors | 1994 |
Effect of erythromycin on postprandial gastroesophageal reflux in reflux esophagitis.
Topics: Adult; Anti-Bacterial Agents; Eating; Erythromycin; Esophagitis, Peptic; Esophagus; Female; Gastroesophageal Reflux; Gastrointestinal Agents; Humans; Hydrogen-Ion Concentration; Injections, Intravenous; Male; Middle Aged; Single-Blind Method; Time Factors | 1997 |
Effect of sequential erythromycin and octreotide on antroduodenal manometry.
Topics: Child; Crohn Disease; Drug Therapy, Combination; Duodenum; Erythromycin; Fasting; Female; Gastroesophageal Reflux; Gastrointestinal Agents; Gastrointestinal Motility; Gastroparesis; Humans; Intestinal Pseudo-Obstruction; Male; Muscle Contraction; Octreotide; Periodicity; Pyloric Antrum; Vomiting | 1999 |
[Anorexia nervosa or somatic disease].
Topics: Adolescent; Anorexia Nervosa; Cisapride; Erythromycin; Female; Gastroesophageal Reflux; Gastrointestinal Agents; Gastrointestinal Motility; Humans; Male; Manometry; Somatoform Disorders | 2001 |